HARTMANN announces price increase

Heidenheim, July 25, 2022. Health care company HARTMANN is announcing further price increases in most product categories and markets to compensate the significantly higher costs for raw material, energy and freight that have been hitting the markets over the course of several months.

“We are facing historically high costs for raw material, energy and freight. We do not expect these costs to decrease in the near term. Our goal is to assure ability to supply. Therefore, price increases play an essential role to compensate for the higher costs and assure continued supply ability. We have taken a wide range of productivity actions to improve our efficiency and reduce costs to help offset the strong inflationary challenges and subsequent pricing. We are confident that appropriate measures will ensure our ability to continue to provide the products and services our customers rely on”, states the HARTMANN Management Board.

The HARTMANN GROUP is one of the leading European providers of professional medical and care products and associated services. Every day, healthcare professionals and patients rely on HARTMANN brands in the segments of Incontinence Management (e.g. MoliCare®), Wound Care (e.g. Zetuvit®, Cosmopor®) and Infection Management (e. g. Sterillium®). This is expressed in our brand promise of “Helps. Cares. Protects.” HARTMANN generated sales of EUR 2.3 billion in the 2023 financial year. Founded in 1818, the Company sells its products and solutions in 130 countries around the world. For the future, the HARTMANN GROUP is currently implementing its strategic Transformation Program with its high-performance, customer-oriented and passionate team.

To learn more about the HARTMANN GROUP, visit www.corporate.hartmann.info.